Presentation Information

[1P-038]Suppression of PLA2G6/iPLA2β in the liver improves ameliorates abnormal glucose and lipid metabolism

Kahori Shimizu1,2,3, Mana Nishibata3, Katsuyuki Nagata4, Sho Hori2, Miyuki Kanehara3, Miho Iwasaki3, Fuminori Sakurai5, Hideo Shindou4,6, Koji Tomita3, Hiroyuki Mizuguchi1,2,7,8,9,10, Toru Nishinaka3 (1.Grad. Sch. of Pharm. Sci., Osaka Univ., 2.Sch. of Pharm. Sci., Osaka Univ., 3.Pharm., Osaka Ohtani Univ., 4.NCGM, 5.Dept. Pharm., Kindai Univ., 6.Univ. of Tokyo, 7.Natl. Inst. of Biomed. Innov. Health Nutr., 8.MEIC, Osaka Univ., 9.OTRI, Osaka Univ., 10.CiDER, Osaka Univ.)
キーテクノロジー:アデノウイルスベクター

Keywords:

ホスホリパーゼ、リン脂質、糖・脂質代謝、アデノウイルスベクター、肝臓

shimizu@phs.osaka-u.ac.jp

Password required to view


Comment

To browse or post comments, you must log in.Log in